FMR LLC

Average Profitability
8.34%
Insider Buys Quantity
5
Insider Buys Sum
$19.71M
Insider Sells Quantity
111
Insider Sells Sum
$148.02M

Insider Activity of FMR LLC

The largest purchase of all time was on 2015-10-13 and amounted to 670910 shares of Aclaris Therapeutics, Inc. for $7.38M.

The largest sale of all time was on 2015-11-25 and amounted to 459192 shares of Blueprint Medicines Corporation for $9.81M.

Biography of FMR LLC

No biography is available at this moment.

2022-07-12SaleVerve Therapeutics, Inc.
VERV
226,000
0.376%
$21.13$4.78M-3.51%
2022-07-01SaleVerve Therapeutics, Inc.
VERV
77,550
0.1358%
$15.66$1.21M+37.59%
2022-06-30SaleVerve Therapeutics, Inc.
VERV
other
18,810
0.0327%
$15.21$286,100+40.18%
2022-06-29SaleVerve Therapeutics, Inc.
VERV
53,219
0.109%
$15.45$822,476+38.19%
2022-03-09SaleVerve Therapeutics, Inc.
VERV
7,942
0.0164%
$29.01$230,397-23.13%
2022-02-09SaleVerve Therapeutics, Inc.
VERV
10 percent owner
26,380
0.0511%
$29.46$777,155-26.8%
2022-02-01SaleVerve Therapeutics, Inc.
VERV
10 percent owner
71,148
0.1467%
$29.04$2.07M-19.9%
2022-01-27SaleVerve Therapeutics, Inc.
VERV
10 percent owner
17,966
0.0408%
$29.28$526,061-12.42%
2022-01-26SaleVerve Therapeutics, Inc.
VERV
10 percent owner
299,706
0.65%
$31.23$9.36M-21.15%
2019-04-01PurchasePrecision BioSciences, Inc.
DTIL
100,000
0.1888%
$16.00$1.6M-35.24%
2016-10-26SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
7,500
0.032%
$21.94$164,519+23.37%
2016-08-08SaleCoherus BioSciences, Inc.
CHRS
200,000
0.4574%
$29.86$5.97M-16.61%
2016-08-05SaleCoherus BioSciences, Inc.
CHRS
10 percent owner
50,000
0.1137%
$28.78$1.44M-13.29%
2016-08-04SaleCoherus BioSciences, Inc.
CHRS
10 percent owner
47,200
0.1088%
$28.16$1.33M-9.97%
2016-05-17SaleREGENXBIO Inc.
RGNX
18,300
0.069%
$12.41$227,103+39.42%
2016-05-16SaleREGENXBIO Inc.
RGNX
10 percent owner
10,500
0.0386%
$11.86$124,534+41.54%
2016-05-13SaleREGENXBIO Inc.
RGNX
10 percent owner
5,530
0.0208%
$11.25$62,231+52.12%
2016-05-12SaleREGENXBIO Inc.
RGNX
10 percent owner
6,711
0.0251%
$10.85$72,833+56.08%
2016-05-11SaleREGENXBIO Inc.
RGNX
10 percent owner
14,189
0.0514%
$10.58$150,135+54.7%
2016-05-10SaleREGENXBIO Inc.
RGNX
10 percent owner
10,943
0.0417%
$10.08$110,318+70.07%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.